| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 103909-75-7 | 馬沙骨化醇 | Maxacalcitol; 1,3-Cyclohexanediol,4-methylene-5-[(2E)-[(1S,3aS,7aS)-octahydro-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-,(1R,3S,5Z)- (9CI); 1,3-Cyclohexanediol,4-methylene-5-[2-[octahydro-1-[1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-,[1S-[1a(R*),3ab,4E(1S*,3R*,5Z),7aa]]-; 1a,25-Dihydroxy-22-oxavitamin D3; 22-Oxa-1,25-Dihydroxyvitamin D3; 22-Oxa-1a,25-dihydroxyvitamin D3; 22-Oxacalcitriol; MC 1275; 1,3-Cyclohexanediol,4-methylene-5-[(2E)-2-[(1S,3aS,7aS)-octahydro-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-,(1R,3S,5Z)-; OCT; OCT (steroid); Oxarol; Prezios; Sch 209579; |  | C26H42O4 | 詳情 | 供應(yīng)商 |
| 131918-61-1 | 帕立骨化醇 | Paricalcitol; 19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol,(1a,3b,7E,22E)- (9CI); 19-Nor-1,25-Dihydroxyvitamin D2; 1a,25-Dihydroxy-19-nor-vitamin D2; 1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-,(1R,3R,5Z)-; Zemplar; |  | C27H44O3 | 詳情 | 供應(yīng)商 |
| 60133-18-8 | 1alpha,25-Dihydroxycalciferol | 1alpha,25-Dihydroxyvitamin D2; 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3,25-triol,(1a,3b,5Z,7E,22E)- (9CI); 1,25-Dihydroxycalciferol; 1,25-Dihydroxyergocalciferol; 1,25-Dihydroxyvitamin D2; 1a,25-Dihydroxycalciferol; 1a,25-Dihydroxyergocalciferol; 1,3-Cyclohexanediol,4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-,(1R,3S,5Z)-; Ercalcitriol; Ro 17-6218; |  | C28H44O3 | 詳情 | 供應(yīng)商 |